Published in Jpn J Ophthalmol on January 31, 2014
Diagnosis and management of intestinal Behçet's disease. Clin J Gastroenterol (2014) 0.87
Association between the major histocompatibility complex and clinical response to infliximab therapy in patients with Behçet uveitis. Jpn J Ophthalmol (2015) 0.75
Pattern and causes of visual loss in Behçet's uveitis: short-term and long-term outcomes. Graefes Arch Clin Exp Ophthalmol (2017) 0.75
Laser flare-cell photometer: principle and significance in clinical and basic ophthalmology. Jpn J Ophthalmol (2016) 0.75
Modified disease activity scores that include twenty-eight-joint counts. Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis. Arthritis Rheum (1995) 26.94
Standardization of uveitis nomenclature for reporting clinical data. Results of the First International Workshop. Am J Ophthalmol (2005) 13.50
A simplified disease activity index for rheumatoid arthritis for use in clinical practice. Rheumatology (Oxford) (2003) 4.86
Acute phase reactants add little to composite disease activity indices for rheumatoid arthritis: validation of a clinical activity score. Arthritis Res Ther (2005) 4.86
Standardization of vitreal inflammatory activity in intermediate and posterior uveitis. Ophthalmology (1985) 3.83
Efficacy, safety, and pharmacokinetics of multiple administration of infliximab in Behçet's disease with refractory uveoretinitis. J Rheumatol (2004) 3.28
Effect of infliximab on sight-threatening panuveitis in Behçet's disease. Lancet (2001) 2.95
Current concepts in the etiology and treatment of Behçet disease. Surv Ophthalmol (2005) 2.48
Psoriasis induced by anti-tumor necrosis factor therapy: a paradoxical adverse reaction. Arthritis Rheum (2005) 2.05
Behçet's disease: evaluation of a new instrument to measure clinical activity. Rheumatology (Oxford) (1999) 1.66
Comparison of patients with Behçet's disease in the 1980s and 1990s. Ophthalmology (2004) 1.16
The 2009 prospective multi-center epidemiologic survey of uveitis in Japan. Jpn J Ophthalmol (2012) 1.11
Evaluating disease activity in rheumatoid arthritis: which composite index is best? A systematic literature analysis of studies comparing the psychometric properties of the DAS, DAS28, SDAI and CDAI. Joint Bone Spine (2011) 1.06
Long-term efficacy of infliximab in refractory posterior uveitis of Behcet's disease: a 24-month follow-up study. Rheumatology (Oxford) (2007) 1.06
Multicenter study of infliximab for refractory uveoretinitis in Behçet disease. Arch Ophthalmol (2012) 1.01
The Behcet's disease activity index. Rheumatology (Oxford) (2003) 0.99
Best-corrected visual acuity and frequency of ocular attacks during the initial 10 years in patients with Behçet's disease. Graefes Arch Clin Exp Ophthalmol (2009) 0.79
Psoriasis triggered by infliximab in a patient with Behçet's disease. Jpn J Ophthalmol (2012) 0.79
Inflammation-induced lymphangiogenesis in the cornea arises from CD11b-positive macrophages. J Clin Invest (2005) 3.77
Genome-wide association studies identify IL23R-IL12RB2 and IL10 as Behçet's disease susceptibility loci. Nat Genet (2010) 2.74
Alternatively spliced vascular endothelial growth factor receptor-2 is an essential endogenous inhibitor of lymphatic vessel growth. Nat Med (2009) 2.39
Infiltration of COX-2-expressing macrophages is a prerequisite for IL-1 beta-induced neovascularization and tumor growth. J Clin Invest (2005) 2.20
High-throughput DNA typing of HLA-A, -B, -C, and -DRB1 loci by a PCR-SSOP-Luminex method in the Japanese population. Immunogenetics (2005) 2.19
Immediate removal of posteriorly dislocated lens fragments through sclerocorneal incision during cataract surgery. Br J Ophthalmol (2012) 2.19
Reduction in choroidal thickness of macular area in polypoidal choroidal vasculopathy patients after intravitreal ranibizumab therapy. Graefes Arch Clin Exp Ophthalmol (2013) 2.06
Comprehensive analysis of inflammatory immune mediators in vitreoretinal diseases. PLoS One (2009) 2.00
Genome-wide association analysis identifies new susceptibility loci for Behçet's disease and epistasis between HLA-B*51 and ERAP1. Nat Genet (2013) 1.93
Comparison of infliximab versus ciclosporin during the initial 6-month treatment period in Behçet disease. Br J Ophthalmol (2009) 1.91
Comparative study of two sets of criteria for the diagnosis of Vogt-Koyanagi-Harada's disease. Am J Ophthalmol (2005) 1.72
Role of IL-12B promoter polymorphism in Adamantiades-Behcet's disease susceptibility: An involvement of Th1 immunoreactivity against Streptococcus Sanguinis antigen. J Invest Dermatol (2006) 1.59
Nuclear cataract caused by a lack of DNA degradation in the mouse eye lens. Nature (2003) 1.55
Genetics of Behçet disease inside and outside the MHC. Ann Rheum Dis (2009) 1.55
Association of Toll-like receptor 4 gene polymorphisms with normal tension glaucoma. Invest Ophthalmol Vis Sci (2008) 1.43
Ocular infiltrating CD4+ T cells from patients with Vogt-Koyanagi-Harada disease recognize human melanocyte antigens. Invest Ophthalmol Vis Sci (2006) 1.41
Characterization and distribution of bone marrow-derived cells in mouse cornea. Invest Ophthalmol Vis Sci (2005) 1.33
Effects of astaxanthin on lipopolysaccharide-induced inflammation in vitro and in vivo. Invest Ophthalmol Vis Sci (2003) 1.32
Enhanced depth imaging optical coherence tomography of the choroid in Vogt-Koyanagi-Harada disease. Retina (2012) 1.32
Detection of Candida and Aspergillus species DNA using broad-range real-time PCR for fungal endophthalmitis. Graefes Arch Clin Exp Ophthalmol (2011) 1.30
Genome-wide association study of normal tension glaucoma: common variants in SRBD1 and ELOVL5 contribute to disease susceptibility. Ophthalmology (2010) 1.28
Choroidal observations in Vogt-Koyanagi-Harada disease using high-penetration optical coherence tomography. Graefes Arch Clin Exp Ophthalmol (2012) 1.28
Use of a comprehensive polymerase chain reaction system for diagnosis of ocular infectious diseases. Ophthalmology (2013) 1.25
Involvement of Th17 cells and the effect of anti-IL-6 therapy in autoimmune uveitis. Rheumatology (Oxford) (2009) 1.25
Cytokine profile in aqueous humor and sera of patients with infectious or noninfectious uveitis. Invest Ophthalmol Vis Sci (2006) 1.22
Clinical features in tubulointerstitial nephritis and uveitis (TINU) syndrome. Am J Ophthalmol (2005) 1.22
iTRAQ-based proteomic identification of leucine-rich alpha-2 glycoprotein as a novel inflammatory biomarker in autoimmune diseases. Ann Rheum Dis (2009) 1.19
The COL1A1 gene and high myopia susceptibility in Japanese. Hum Genet (2007) 1.17
Genetic variants on chromosome 1q41 influence ocular axial length and high myopia. PLoS Genet (2012) 1.17
Targeted resequencing implicates the familial Mediterranean fever gene MEFV and the toll-like receptor 4 gene TLR4 in Behçet disease. Proc Natl Acad Sci U S A (2013) 1.15
Chronic photo-oxidative stress and subsequent MCP-1 activation as causative factors for age-related macular degeneration. J Cell Sci (2012) 1.15
Suppression of experimental autoimmune uveoretinitis by inducing differentiation of regulatory T cells via activation of aryl hydrocarbon receptor. Invest Ophthalmol Vis Sci (2009) 1.14
Elevation of serum Krebs von den Lunge-6 levels in patients with tubulointerstitial nephritis and uveitis syndrome. Am J Kidney Dis (2006) 1.14
Vogt-Koyanagi-Harada disease occurring during interferon alpha therapy for chronic hepatitis C. J Gastroenterol (2004) 1.13
Spontaneous regression of intraocular lymphoma. Ophthalmology (2012) 1.13
A randomized, placebo-controlled clinical trial of tacrolimus ophthalmic suspension 0.1% in severe allergic conjunctivitis. J Ocul Pharmacol Ther (2010) 1.12
Genetic polymorphisms in the promoter of the interferon gamma receptor 1 gene are associated with atopic cataracts. Invest Ophthalmol Vis Sci (2007) 1.12
Inducible immune regulation following autoimmune disease in the immune-privileged eye. J Leukoc Biol (2005) 1.11
Japanese guideline for allergic conjunctival diseases. Allergol Int (2011) 1.10
Genome-wide association study identifies GIMAP as a novel susceptibility locus for Behcet's disease. Ann Rheum Dis (2012) 1.10
Trans-Tenon's retrobulbar triamcinolone infusion for diffuse diabetic macular edema. Graefes Arch Clin Exp Ophthalmol (2004) 1.08
Risk and prognostic factors of poor visual outcome in Behcet's disease with ocular involvement. Graefes Arch Clin Exp Ophthalmol (2005) 1.07
Tumor growth and angiogenesis are dependent on the presence of immature dendritic cells. FASEB J (2009) 1.06
Nine loci for ocular axial length identified through genome-wide association studies, including shared loci with refractive error. Am J Hum Genet (2013) 1.06
Confirmation of TBK1 duplication in normal tension glaucoma. Exp Eye Res (2012) 1.06
Choroidal and cutaneous metastasis from gastric adenocarcinoma. World J Gastroenterol (2013) 1.06
Blockade of interleukin-6 signaling suppresses experimental autoimmune uveoretinitis by the inhibition of inflammatory Th17 responses. Exp Eye Res (2010) 1.05
The eye's view of antigen presentation. Hum Immunol (2002) 1.05
Amelioration of experimental autoimmune uveoretinitis (EAU) with an inhibitor of nuclear factor-kappaB (NF-kappaB), pyrrolidine dithiocarbamate. J Leukoc Biol (2006) 1.05
Clinical findings in unilateral acute idiopathic maculopathy: new findings in acute idiopathic maculopathy. Int Ophthalmol (2009) 1.04
Choroidal thickness in central serous chorioretinopathy. Retina (2013) 1.04
Chemokine and chemokine receptor expression during experimental autoimmune uveoretinitis in mice. Graefes Arch Clin Exp Ophthalmol (2003) 1.04
Retinal pigment epithelium-derived CTLA-2alpha induces TGFbeta-producing T regulatory cells. J Immunol (2008) 1.03
Preoperative endovascular embolization for hemangioblastoma in the posterior fossa. Neurol Med Chir (Tokyo) (2012) 1.03
Functional expression of B7H1 on retinal pigment epithelial cells. Exp Eye Res (2007) 1.02
Dendritic cells support angiogenesis and promote lesion growth in a murine model of endometriosis. FASEB J (2007) 1.02
Immunohistochemical detection of IDH1 mutation, p53, and internexin as prognostic factors of glial tumors. J Neurooncol (2012) 1.01
Tolerability and efficacy of N-chlorotaurine in epidemic keratoconjunctivitis--a double-blind, randomized, phase-2 clinical trial. J Ocul Pharmacol Ther (2005) 1.01
Vitreous surgery for macular hole in patients with Vogt-Koyanagi-Harada disease. Clin Experiment Ophthalmol (2008) 1.01
Relationship between choroidal blood flow velocity and choroidal thickness during systemic corticosteroid therapy for Vogt-Koyanagi-Harada disease. Graefes Arch Clin Exp Ophthalmol (2015) 1.01
Reversible holocord edema associated with intramedullary spinal abscess secondary to an infected dermoid cyst. Pediatr Neurosurg (2002) 1.01
Anterior segment optical coherence tomography findings of presumed intraocular tuberculosis. Cutan Ocul Toxicol (2010) 1.00
Immunological homeostasis of the eye. Prog Retin Eye Res (2012) 1.00
Elevated choroidal blood flow velocity during systemic corticosteroid therapy in Vogt-Koyanagi-Harada disease. Acta Ophthalmol (2008) 0.99
Induction of eye-derived tolerance does not depend on naturally occurring CD4+CD25+ T regulatory cells. Invest Ophthalmol Vis Sci (2006) 0.99
Correlation of vascular endothelial growth factor with chemokines in the vitreous in diabetic retinopathy. Retina (2010) 0.97
ABCA4 gene mutations in Japanese patients with Stargardt disease and retinitis pigmentosa. Invest Ophthalmol Vis Sci (2002) 0.97
A case of Behçet's disease treated with a humanized anti-interleukin-6 receptor antibody, tocilizumab. Mod Rheumatol (2011) 0.96
Acute subdural hematoma without subarachnoid hemorrhage caused by ruptured A1-A2 junction aneurysm. Case report. Neurol Med Chir (Tokyo) (2012) 0.96
Cdk5/p35 and Rho-kinase mediate ephrin-A5-induced signaling in retinal ganglion cells. Mol Cell Neurosci (2003) 0.96
Evaluation of pulse corticosteroid therapy for vogt-koyanagi-harada disease assessed by optical coherence tomography. Am J Ophthalmol (2002) 0.96
Relation of intraocular concentrations of inflammatory factors and improvement of macular edema after vitrectomy in branch retinal vein occlusion. Am J Ophthalmol (2011) 0.95
Blockade of interleukin-6 signaling suppresses not only th17 but also interphotoreceptor retinoid binding protein-specific Th1 by promoting regulatory T cells in experimental autoimmune uveoretinitis. Invest Ophthalmol Vis Sci (2011) 0.95
Behçet's disease: global epidemiology of an Old Silk Road disease. Br J Ophthalmol (2007) 0.95
Association of TLR4 polymorphisms with Behcet's disease in a Korean population. Rheumatology (Oxford) (2009) 0.94
Treatment of primary intraocular lymphoma with intravitreal methotrexate. Jpn J Ophthalmol (2008) 0.94
Association of Major Histocompatibility Complex Class I Chain-Related Gene A and HLA-B Alleles with Behçet's Disease in Turkey. Jpn J Ophthalmol (2007) 0.93
Prevention of experimental autoimmune uveoretinitis by vasoactive intestinal peptide. Arch Ophthalmol (2004) 0.92
Navigation-guided endoscopic biopsy for intraparenchymal brain tumor. Neurol Med Chir (Tokyo) (2011) 0.92
Intravitreal injection of Tacrolimus (FK506) suppresses ongoing experimental autoimmune uveoretinitis in Rats. Br J Ophthalmol (2006) 0.92
Comparison of patients with ocular tuberculosis in the 1990s and the 2000s. Jpn J Ophthalmol (2010) 0.92
Analysis of choroidal folds in acute Vogt-Koyanagi-Harada disease using high-penetration optical coherence tomography. Graefes Arch Clin Exp Ophthalmol (2015) 0.92
Low peripheral lymphocyte count before focal radiotherapy plus concomitant temozolomide predicts severe lymphopenia during malignant glioma treatment. Neurol Med Chir (Tokyo) (2010) 0.92
Immune responses to retinal self-antigens in CD25(+)CD4(+) regulatory T-cell-depleted mice. Invest Ophthalmol Vis Sci (2004) 0.92
Intraocular VEGF level as a risk factor for postoperative complications after vitrectomy for proliferative diabetic retinopathy. Invest Ophthalmol Vis Sci (2012) 0.91
Neutrophil chemotaxis and local expression of interleukin-10 in the tolerance of endotoxin-induced uveitis. Invest Ophthalmol Vis Sci (2008) 0.91
Role of IL-22- and TNF-α-producing Th22 cells in uveitis patients with Behcet's disease. J Immunol (2013) 0.91
Suppression of experimental autoimmune uveitis by angiotensin II type 1 receptor blocker telmisartan. Invest Ophthalmol Vis Sci (2009) 0.91
Comparisons of microRNA expression profiles in vitreous humor between eyes with macular hole and eyes with proliferative diabetic retinopathy. Graefes Arch Clin Exp Ophthalmol (2014) 0.90
Blood level of tacrolimus in patients with severe allergic conjunctivitis treated by 0.1% tacrolimus ophthalmic suspension. Allergol Int (2012) 0.90
Anti-inflammatory effects of alpha-melanocyte-stimulating hormone against rat endotoxin-induced uveitis and the time course of inflammatory agents in aqueous humor. Int Immunopharmacol (2004) 0.90